Two-medication strategy offers both benefit and risk after coronary artery bypass surgery - Medical Xpress

8/9/2022 12:00:00 AM2 years 9 months ago
by Science X staff
by Science X staff
A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery—while also increasing the risk of potentially dangerous bleeding. This double-edged finding from Weill Cornell Medicine and …
A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgerywhile also increasing the risk of potentially dangerous bleeding.… [+3838 chars]
full article...